cancer research

The Ohio Classic, scheduled for July 11th, is Ohio’s first official B2B golf event dedicated to advancing the cannabis industry while supporting brain tumor research. This event provides opportunities to engage with local brands and industry experts through panel discussions, networking ...

A new scanning method that involves a see-through mouse could revolutionize how cancer drugs are tested by detecting tumors that were previously too small to identify, BBC News reports. Revolutionary Scanning Method Prof. Ali Ertürk of the Helmholtz Munich research centre has developed a technique...

An artificial intelligence (AI) tool, the Cryosection Histopathology Assessment and Review Machine (CHARM), is showing promise in aiding doctors in the fight against aggressive brain tumors. CHARM can quickly identify the genetic profile of a glioma tumor, a process that currently takes days or...

Detecting cancer early is critical to beating the disease. But many people don't catch their cancer until it's already progressed, significantly reducing their potential for remission. Ezra, a New York-based company, has developed a full-body MRI scanner that can scan up to 13 organs in the human...

A week after filing for an initial public offering with the Securities and Exchange Commission, reports are suggesting that the cancer detection startup Grail Inc. could be acquired by a larger healthcare company. What Happened: According to Bloomberg, Illumina Inc (NASDAQ: ILMN) is valuing Grail...

Allogene Therapeutics is set to begin trading on the Nasdaq Stock Exchange under the ticker symbol “ALLO.” The stock is expected to debut Thursday, Oct. 11, although an official IPO date has not yet been released. The Details San Francisco-based Allogene intends to raise $288 million...